CHA
BNTX icon

Carmichael Hill & Associates’s BioNTech BNTX Stock Holding History

Carmichael Hill & Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.19K Hold
10
– – ﹤0.01% 731
2024
Q2 		$804 Hold
10
– – ﹤0.01% 735
2024
Q1 		$923 Hold
10
– – ﹤0.01% 722
2023
Q4 		$1.06K Hold
10
– – ﹤0.01% 738
2023
Q3 		$1.09K Hold
10
– – ﹤0.01% 728
2023
Q2 		$1.08K Hold
10
– – ﹤0.01% 733
2023
Q1 		$1.25K Hold
10
– – ﹤0.01% 717
2022
Q4 		$1.5K Hold
10
– – ﹤0.01% 705
2022
Q3 		$1K Hold
10
– – ﹤0.01% 763
2022
Q2 		$1K Hold
10
– – ﹤0.01% 750
2022
Q1 		$2K Sell
10
-10
-50% -$1.68K ﹤0.01% 740
2021
Q4 		$5K Sell
20
-20
-50% -$5.48K ﹤0.01% 698
2021
Q3 		$11K Hold
40
– – 0.01% 589
2021
Q2 		$9K Hold
40
– – ﹤0.01% 606
2021
Q1 		$4K Sell
40
-50
-56% -$5.31K ﹤0.01% 668
2020
Q4 		$7K Sell
90
-115
-56% -$11.3K ﹤0.01% 590
2020
Q3 		$14K Buy
205
+100
+95% +$7.17K 0.01% 475
2020
Q2 		$7K Buy
+105
New +$5.24K 0.01% 528

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carmichael Hill & Associates's BNTX Position: Q3 2024 in Review

Carmichael Hill & Associates held its BioNTech (BNTX) position steady in Q3 2024 at 10 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Carmichael Hill & Associates first reported a position in BNTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $14K in Q3 2020. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Carmichael Hill & Associates held 10 shares of BioNTech worth $1.19K as of Q3 2024.
  • Carmichael Hill & Associates left its BioNTech share count unchanged in Q3 2024.
  • BioNTech made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #731 holding.
  • Carmichael Hill & Associates first reported a position in BioNTech in Q2 2020 and has held it in 18 quarters since.
  • Carmichael Hill & Associates's BioNTech position peaked at $14K in Q3 2020.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.